血栓通注射液联合依达拉奉治疗急性脑梗死疗效观察

被引:38
作者
姬莉
沙瑞娟
刘夕珍
张宙
丁元良
机构
[1] 南京医科大学附属南京脑科医院
关键词
脑梗死; 依达拉奉; 血栓通注射液; 神经功能缺损评分;
D O I
暂无
中图分类号
R743.33 [脑栓塞];
学科分类号
摘要
目的观察血栓通注射液联合依达拉奉治疗急性脑梗死的疗效及不良反应。方法对98例发病3d内的脑梗死患者随机分为两组,对照组50例进行常规基础治疗,血栓通注射液4mL静脉滴注,每日1次;治疗组48例在对照组的基础上,以依达拉奉30mg静脉滴注,2次/日,连用14d。2周后行神经功能缺损评分,记录用药的不良反应。结果治疗组神经功能缺损评分较对照组下降明显,治疗组总有效率为91.67%,对照组总有效率为82.00%,两组比较有统计学意义(P<0.05)。各项安全性指标检测在正常范围。结论血栓通注射液联合依达拉奉治疗急性脑梗死的疗效显著安全。
引用
收藏
页码:377 / 379
页数:3
相关论文
共 7 条
  • [1] 人参皂苷Rg1处理的人神经干细胞对缺氧缺血脑损伤的功能恢复研究[J]. 李英博,涂柳,陈笛,姜蓉,王亚平,王莎莉.中国中药杂志. 2012(04)
  • [3] Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury[J] . Manabu Ohta,Youichirou Higashi,Toshio Yawata,Masahiro Kitahara,Atsuya Nobumoto,Eri Ishida,Masayuki Tsuda,Yasunori Fujimoto,Keiji Shimizu.Brain Research . 2013
  • [4] Ginsenoside Rg1 prevents SK-N-SH neuroblastoma cell apoptosis induced by supernatant from Aβ 1–40 -stimulated THP-1 monocytes[J] . Wei Li,Yanqi Chu,Lan Zhang,Linlin Yin,Lin Li.Brain Research Bulletin . 2012 (5)
  • [5] Beyond free radical scavenging: Beneficial effects of edaravone (Radicut)in various diseases (Review)[J] . Kiyoshi Kikuchi,Nobuyuki Takeshige,Naoki Miura,Yoko Morimoto,Takashi Ito,Salunya Tancharoen,Kei Miyata,Chiemi Kikuchi,Narumi Iida,Hisaaki Uchikado,Naohisa Miyagi,Naoto Shiomi,Terukazu Kuramoto,Ikuro Maruyama,Motohiro Morioka,Ko-Ichi Kawahara.Experimental and Therapeutic Medicine . 2012 (1)
  • [6] Phase I Clinical Study of Edaravone in Healthy Chinese Volunteers[J] . Hao Li,Kun Xu,Yongqing Wang,Hongwen Zhang,Tianping Li,Ling Meng,Xiaojian Gong,Haibo Zhang,Ning Ou,Jinman Ruan.Drugs in R&D . 2012 (2)
  • [7] Surgical Decompression Improves Mortality and Morbidity After Large Territory Acute Cerebral Infarction: A Critically Appraised Topic[J] . Amaal J. Starling,Kay E. Wellik,Charlene R. Hoffman Snyder,Maria I. Aguilar,Bart M. Demaerschalk,Richard S. Zimmerman,Dean M. Wingerchuk.The Neurologist . 2011 (1)